Copyright Reports & Markets. All rights reserved.

Global Point-of-care Testing (POCT) for Infectious Diseases Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Based on Colloidal Gold
    • 1.3.3 Based on Chemiluminescence
    • 1.3.4 Based on Fluorescence Immunochromatography
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 lndependent Testing Organization
  • 1.5 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size & Forecast
    • 1.5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (2021-2032)
    • 1.5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.1.4 Roche Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.2.4 Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Recent Developments/Updates
  • 2.3 Siemens Healthineers
    • 2.3.1 Siemens Healthineers Details
    • 2.3.2 Siemens Healthineers Major Business
    • 2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Siemens Healthineers Recent Developments/Updates
  • 2.4 Danaher
    • 2.4.1 Danaher Details
    • 2.4.2 Danaher Major Business
    • 2.4.3 Danaher Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.4.4 Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Danaher Recent Developments/Updates
  • 2.5 BD
    • 2.5.1 BD Details
    • 2.5.2 BD Major Business
    • 2.5.3 BD Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.5.4 BD Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BD Recent Developments/Updates
  • 2.6 Assure Tech
    • 2.6.1 Assure Tech Details
    • 2.6.2 Assure Tech Major Business
    • 2.6.3 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.6.4 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Assure Tech Recent Developments/Updates
  • 2.7 BioMerieux
    • 2.7.1 BioMerieux Details
    • 2.7.2 BioMerieux Major Business
    • 2.7.3 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.7.4 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BioMerieux Recent Developments/Updates
  • 2.8 Bio-Rad Laboratories
    • 2.8.1 Bio-Rad Laboratories Details
    • 2.8.2 Bio-Rad Laboratories Major Business
    • 2.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.8.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bio-Rad Laboratories Recent Developments/Updates
  • 2.9 Wondfo
    • 2.9.1 Wondfo Details
    • 2.9.2 Wondfo Major Business
    • 2.9.3 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.9.4 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Wondfo Recent Developments/Updates
  • 2.10 Wuhan Easy Diagnosis
    • 2.10.1 Wuhan Easy Diagnosis Details
    • 2.10.2 Wuhan Easy Diagnosis Major Business
    • 2.10.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.10.4 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Wuhan Easy Diagnosis Recent Developments/Updates
  • 2.11 Getein Biotech
    • 2.11.1 Getein Biotech Details
    • 2.11.2 Getein Biotech Major Business
    • 2.11.3 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.11.4 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Getein Biotech Recent Developments/Updates
  • 2.12 Beijing Hotgen Biotech Co.,ltd.
    • 2.12.1 Beijing Hotgen Biotech Co.,ltd. Details
    • 2.12.2 Beijing Hotgen Biotech Co.,ltd. Major Business
    • 2.12.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.12.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
  • 2.13 Beijing Wantai BioPharm
    • 2.13.1 Beijing Wantai BioPharm Details
    • 2.13.2 Beijing Wantai BioPharm Major Business
    • 2.13.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.13.4 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Beijing Wantai BioPharm Recent Developments/Updates
  • 2.14 Zhejiang Orient Gene Biotech Co.,Ltd.
    • 2.14.1 Zhejiang Orient Gene Biotech Co.,Ltd. Details
    • 2.14.2 Zhejiang Orient Gene Biotech Co.,Ltd. Major Business
    • 2.14.3 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.14.4 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
  • 2.15 Sansure Biotech Inc.
    • 2.15.1 Sansure Biotech Inc. Details
    • 2.15.2 Sansure Biotech Inc. Major Business
    • 2.15.3 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
    • 2.15.4 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Sansure Biotech Inc. Recent Developments/Updates

3 Competitive Environment: Point-of-care Testing (POCT) for Infectious Diseases by Manufacturer

  • 3.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Manufacturer (2021-2026)
  • 3.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Infectious Diseases by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer Market Share in 2025
  • 3.5 Point-of-care Testing (POCT) for Infectious Diseases Market: Overall Company Footprint Analysis
    • 3.5.1 Point-of-care Testing (POCT) for Infectious Diseases Market: Region Footprint
    • 3.5.2 Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Type Footprint
    • 3.5.3 Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region
    • 4.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2021-2032)
    • 4.1.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Region (2021-2032)
  • 4.2 North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2021-2032)
  • 4.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2021-2032)
  • 4.5 South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2021-2032)
  • 5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type (2021-2032)
  • 5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2021-2032)
  • 6.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application (2021-2032)
  • 6.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2021-2032)
  • 7.2 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2021-2032)
  • 7.3 North America Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
    • 7.3.1 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2021-2032)
  • 8.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2021-2032)
  • 8.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
    • 8.3.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region
    • 9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2021-2032)
  • 10.2 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2021-2032)
  • 10.3 South America Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
    • 10.3.1 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
    • 11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Point-of-care Testing (POCT) for Infectious Diseases Market Drivers
  • 12.2 Point-of-care Testing (POCT) for Infectious Diseases Market Restraints
  • 12.3 Point-of-care Testing (POCT) for Infectious Diseases Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Point-of-care Testing (POCT) for Infectious Diseases and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Infectious Diseases
  • 13.3 Point-of-care Testing (POCT) for Infectious Diseases Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Point-of-care Testing (POCT) for Infectious Diseases Typical Distributors
  • 14.3 Point-of-care Testing (POCT) for Infectious Diseases Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Infectious Diseases market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Infectious Diseases market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Infectious Diseases market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Point-of-care Testing (POCT) for Infectious Diseases
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Point-of-care Testing (POCT) for Infectious Diseases market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens Healthineers, Danaher, BD, Assure Tech, BioMerieux, Bio-Rad Laboratories, Wondfo, Wuhan Easy Diagnosis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Point-of-care Testing (POCT) for Infectious Diseases market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Based on Colloidal Gold
    Based on Chemiluminescence
    Based on Fluorescence Immunochromatography
    Other
    Market segment by Application
    Hospital
    lndependent Testing Organization
    Major players covered
    Roche
    Abbott
    Siemens Healthineers
    Danaher
    BD
    Assure Tech
    BioMerieux
    Bio-Rad Laboratories
    Wondfo
    Wuhan Easy Diagnosis
    Getein Biotech
    Beijing Hotgen Biotech Co.,ltd.
    Beijing Wantai BioPharm
    Zhejiang Orient Gene Biotech Co.,Ltd.
    Sansure Biotech Inc.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Point-of-care Testing (POCT) for Infectious Diseases product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Infectious Diseases, with price, sales quantity, revenue, and global market share of Point-of-care Testing (POCT) for Infectious Diseases from 2021 to 2026.
    Chapter 3, the Point-of-care Testing (POCT) for Infectious Diseases competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Point-of-care Testing (POCT) for Infectious Diseases breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Point-of-care Testing (POCT) for Infectious Diseases market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Infectious Diseases.
    Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Infectious Diseases sales channel, distributors, customers, research findings and conclusion.

    Buy now